Poor Efficacy of Immune Checkpoint Inhibitors Plus Chemotherapy in Lung Cancer Patients with EGFR/ERBB2 Exon 20 Insertion

Poor Efficacy of Immune Checkpoint Inhibitors Plus Chemotherapy in Lung Cancer Patients with EGFR/ERBB2 Exon 20 Insertion

Background: EGFR and ERBB2 exon 20 insertion (Ex20ins) account for a small fraction of patients with EGFR mutations. The efficacy of immune checkpoint inhibitors (ICIs) for these patients was still controversial. Methods: This retrospective study enrolled lung cancer patients harboring either EGFR o...

Full description

Bibliographic Details
Main Authors: Yue Zheng, Yang Fu, Yueyun Chen, Qing Li, Ting Liu, Zhenyu Ding
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Current Oncology
Subjects:
EGFR
ERBB2
exon 20 insertion
immunochemotherapy
lung cancer
Online Access:https://www.mdpi.com/1718-7729/30/11/721

Internet

https://www.mdpi.com/1718-7729/30/11/721

Similar Items